CAMPUS NEWSCleland, Barnes, Chace tackle tough issues at smart growth forumConvocation begins 'four-year adrenaline rush' for '2003'First person: Gruber recalls a time when 'discussion' wasn't everythingJohn Boli brings global perspective to Senate presidencyConstruction vs. trees: a difficult debate for Emory campusVisit by Belgian prince kicks off exhibit at Carlos MuseumIt's goodbye Black Rose, hello 'fools' for Theater EmoryMusic season full of choices from September through next MayTechnology
source: The millennium bug: It's time for contingency planning
|
SCHOLARSHIP AND RESEARCHSeminar looks at 'unusual' people on both ends of spectrumNew French studies course focuses on aesthetics, analysisCommunity Charities honors Emory doc for sickle cell work Assistant Professor of Pediatrics Lewis Hsu received the Health Advancement Award from Community Health Charities of Georgia at the organization's first annual recognition gala earlier this year. Hsu led the Emory component of the national Stroke Prevention Trial in Sickle Cell Anemia, a federal study showing that monthly blood transfusions prevent stroke in children at the highest risk-usually about one in 12 with sickle cell disease. The study's early results were so positive that the National Institutes of Health halted it midstream in 1997, giving patients nationwide access to the new therapy. Hsu helps care for more than 1,000 of the state's children and adults at the Georgia Comprehensive Sickle Cell Center at Grady and Hughes Spalding hospitals. Patients from as far away as London, Cuba, Zambia and Saudi Arabia have come to the center--one of the best kept secrets in Atlanta, according to Hsu. Health care delivery with high patient satisfaction and a positive bottom line has netted the center a bevy of regional and national awards. Its web site, regarded as one of the best Internet health information sites, is located at <www.cc.emory.edu/PEDS/SICKLE/>.
Emory researcher named Pew Scholar John Altman, assistant professor of microbiology and immunology, has been named a 1999 Pew Scholar. He is one of 20 biomedical researchers nationwide to be so honored. Each of the scientists, junior faculty at medical schools and research institutions, receives a total award of $200,000 over a four-year period. The awards are intended to encourage scholarly innovation in research and to help advance the recipient's knowledge in the biomedical sciences. The awards provide flexible support to the researchers as they establish their laboratories and continue research in areas ranging from AIDS to cancer to childhood infectious diseases and those of the elderly. "These young scientists are the lifeblood of the research community," said Rebecca Rimel, president of The Pew Charitable Trusts. "After 15 years of funding the Scholar's Program, we continue to see great value in nurturing outstanding young scientists to become tomorrow's leading investigators at the forefront of their fields." Altman was chosen for his research on rational approaches to vaccine development and analysis for HIV and selected by a 16-member national advisory committee chaired by Torsten Wiesel, president emeritus of Rockefeller University and 1981 Nobel laureate in medicine. |